Bridge to Recovery and Weaning Protocols

Heart Failure Clinics

Volumn 10, Issue 1 SUPPL., 2014, Pages

  Ibrahim, Michael ^a   Yacoub, Magdi H ^a  

^a HAREFIELD HOSPITAL   (United Kingdom)

Author keywords

Bridge to recovery; Heart failure; LVAD

Indexed keywords

BRIDGE TO RECOVERY; CIRCULATION; CLINICAL PROTOCOL; DISEASE COURSE; HEART FAILURE; HEART MUSCLE; HUMAN; ISCHEMIC CARDIOMYOPATHY; LEFT VENTRICULAR ASSIST DEVICE; MONITORING; MYOCARDITIS; PATIENT SELECTION; QUALITY OF LIFE; REVIEW; SURVIVAL; TIME;

BRIDGE TO RECOVERY; HEART FAILURE; LVAD;

HEART FAILURE; HEART VENTRICLES; HEART-ASSIST DEVICES; HUMANS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84888044314     PISSN: 15517136     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hfc.2013.08.004     Document Type: Review

References (63)

1. Corp T. Thoratec surpasses 10,000 HeartMate II® implants worldwide. 2012. Available at: Accessed October 11, 2013. http://www.prnewswire.com/news-releases/thoratec-surpasses-10000-heartmate-ii-implants-worldwide-147728955.html.
2. Stevenson L.W., Hunt S.A. Abridge far enough?. Circulation 2012, 125:3069-3072.
3. Aaronson K.D., Slaughter M.S., Miller L.W., et al. Use of an intrapericardial, continuous-flow, centrifugal pump in patients awaiting heart transplantation. Circulation 2012, 125:3191-3200.
4. Ibrahim M., Terracciano C.M., Yacoub M.H. Bridge to recovery: what remains to be discovered?. Cardiol Clin 2011, 29:531-547.
5. Yacoub M.H., Terracciano C.M. Bridge to recovery and the search for decision nodes. Circ Heart Fail 2011, 4:393-395.
6. Terracciano C.M., Miller L.W., Yacoub M.H. Contemporary use of ventricular assist devices. Annu Rev Med 2010, 61:255-270.
7. Yacoub M.H., Miller L.W. Long-term left-ventricular-assist-device therapy is here to stay. Nat Clin Pract Cardiovasc Med 2008, 5:60-61.
8. Yacoub M.H., Terracciano C.M. The Holy Grail of LVAD-induced reversal of severe chronic heart failure: the need for integration. Eur Heart J 2011, 32:1052-1054.
9. Pfeffer M.A., Braunwald E. Ventricular remodeling after myocardial infarction. Experimental observations and clinical implications. Circulation 1990, 81:1161-1172.
10. Kass D.A., Baughman K.L., Pak P.H., et al. Reverse remodeling from cardiomyoplasty in human heart failure. External constraint versus active assist. Circulation 1995, 91:2314-2318.
11. Koitabashi N., Kass D.A. Reverse remodeling in heart failure-mechanisms and therapeutic opportunities. Nat Rev Cardiol 2012, 9:147-157.
12. Terracciano C.M., Hardy J., Birks E.J., et al. Clinical recovery from end-stage heart failure using left-ventricular assist device and pharmacological therapy correlates with increased sarcoplasmic reticulum calcium content but not with regression of cellular hypertrophy. Circulation 2004, 109:2263-2265.
13. Ibrahim M., Kukadia P., Siedlecka U., et al. Cardiomyocyte Ca(2+) handling and structure is regulated by degree and duration of mechanical load variation. JCell Mol Med 2012, 16:2910-2918.
14. Buyandelger B., Ng K.E., Miocic S., et al. Genetics of mechanosensation in the heart. JCardiovasc Transl Res 2011, 4:238-244.
15. Frazier O.H., Benedict C.R., Radovancevic B., et al. Improved left ventricular function after chronic left ventricular unloading. Ann Thorac Surg 1996, 62:675-681. [discussion: 681-2].
16. George R.S., Yacoub M.H., Bowles C.T., et al. Quality of life after removal of left ventricular assist device for myocardial recovery. JHeart Lung Transplant 2008, 27:165-172.
17. Kirklin J.K., Naftel D.C., Stevenson L.W., et al. INTERMACS database for durable devices for circulatory support: first annual report. JHeart Lung Transplant 2008, 27:1065-1072.
18. Pagani F.D., Miller L.W., Russell S.D., et al. Extended mechanical circulatory support with a continuous-flow rotary left ventricular assist device. JAm Coll Cardiol 2009, 54:312-321.
19. Slaughter M.S., Rogers J.G., Milano C.A., et al. Advanced heart failure treated with continuous-flow left ventricular assist device. NEngl J Med 2009, 361:2241-2251.
20. Stewart G.C., Stevenson L.W. Keeping left ventricular assist device acceleration on track. Circulation 2011, 123:1559-1568. [discussion: 1568].
21. Miller L.W. Left ventricular assist devices are underutilized. Circulation 2011, 123:1552-1558. [discussion: 1558].
22. NHLBI. REVIVE-IT. Available at: Accessed October 11, 2013. http://clinicaltrials.gov/ct2/results?termREVIVE-IT.
23. Birks E.J., Tansley P.D., Hardy J., et al. Left ventricular assist device and drug therapy for the reversal of heart failure. NEngl J Med 2006, 355:1873-1884.
24. Navaratnarajah M., Ibrahim M., Siedlecka U., et al. Influence of ivabradine on reverse remodelling during mechanical unloading. Cardiovasc Res 2013, 97:230-239.
25. Birks E.J., George R.S., Hedger M., et al. Reversal of severe heart failure with a continuous-flow left ventricular assist device and pharmacological therapy: a prospective study. Circulation 2011, 123:381-390.
26. Toumazou C, MC, Vandevoorde R, Inventor. Implantable surface acoustic wave devices for long term clinical monitoring 2009.
27. Maybaum S., Mancini D., Xydas S., et al. Cardiac improvement during mechanical circulatory support: a prospective multicenter study of the LVAD Working Group. Circulation 2007, 115:2497-2505.
28. Oriyanhan W., Tsuneyoshi H., Nishina T., et al. Determination of optimal duration of mechanical unloading for failing hearts to achieve bridge to recovery in a rat heterotopic heart transplantation model. JHeart Lung Transplant 2007, 26:16-23.
29. Dalby M.C., Banner N.R., Tansley P., et al. Left ventricular function during support with an asynchronous pulsatile left ventricular assist device. JHeart Lung Transplant 2003, 22:292-300.
30. George R.S., Sabharwal N.K., Webb C., et al. Echocardiographic assessment of flow across continuous-flow ventricular assist devices at low speeds. JHeart Lung Transplant 2010, 29:1245-1252.
31. Mancini D.M., Beniaminovitz A., Levin H., et al. Low incidence of myocardial recovery after left ventricular assist device implantation in patients with chronic heart failure. Circulation 1998, 98:2383-2389.
32. Yacoub M.H. Anovel strategy to maximize the efficacy of left ventricular assist devices as a bridge to recovery. Eur Heart J 2001, 22(7):534-540.
33. Kinoshita M., Takano H., Taenaka Y., et al. Cardiac disuse atrophy during LVAD pumping. ASAIO Trans 1988, 34:208-212.
34. Ibrahim M., Al Masri A., Navaratnarajah M., et al. Prolonged mechanical unloading affects cardiomyocyte excitation-contraction coupling, transverse-tubule structure, and the cell surface. FASEB J 2010, 24:3321-3329.
35. Thompson L.O., Skrabal C.A., Loebe M., et al. Plasma neurohormone levels correlate with left ventricular functional and morphological improvement in LVAD patients. JSurg Res 2005, 123:25-32.
36. Felkin L.E., Lara-Pezzi E., George R., et al. Expression of extracellular matrix genes during myocardial recovery from heart failure after left ventricular assist device support. JHeart Lung Transplant 2009, 28:117-122.
37. Potapov E.V., Schweiger M., Krabatsch T. Percutaneous balloon occlusion of a left ventricular assist device outflow cannula to facilitate evaluation of myocardial recovery. JHeart Lung Transplant 2011, 30:1300-1301.
38. Dandel M., Weng Y., Siniawski H., et al. Prediction of cardiac stability after weaning from left ventricular assist devices in patients with idiopathic dilated cardiomyopathy. Circulation 2008, 118(Suppl 14):S94-S105.
39. Dandel M., Weng Y., Siniawski H., et al. Pre-explant stability of unloading-promoted cardiac improvement predicts outcome after weaning from ventricular assist devices. Circulation 2012, 126(11 Suppl 1):S9-S19.
40. Rose E.A., Gelijns A.C., Moskowitz A.J., et al. Long-term use of a left ventricular assist device for end-stage heart failure. NEngl J Med 2001, 345:1435-1443.
41. Drakos S.G., Kfoury A.G., Hammond E.H., et al. Impact of mechanical unloading on microvasculature and associated central remodeling features of the failing human heart. JAm Coll Cardiol 2010, 56:382-391.
42. Bruggink A.H., van Oosterhout M.F., de Jonge N., et al. Reverse remodeling of the myocardial extracellular matrix after prolonged left ventricular assist device support follows a biphasic pattern. JHeart Lung Transplant 2006, 25:1091-1098.
43. Speranza L., Franceschelli S., Riccioni G. The biological effects of ivabradine in cardiovascular disease. Molecules 2012, 17:4924-4935.
44. Greene A.L., Lalli M.J., Ji Y., et al. Overexpression of SERCA2b in the heart leads to an increase in sarcoplasmic reticulum calcium transport function and increased cardiac contractility. JBiol Chem 2000, 275:24722-24727.
45. Lyon A.R., Bannister M.L., Collins T., et al. SERCA2a gene transfer decreases sarcoplasmic reticulum calcium leak and reduces ventricular arrhythmias in a model of chronic heart failure. Circ Arrhythm Electrophysiol 2011, 4:362-372.
46. Lyon A.R., Nikolaev V.O., Miragoli M., et al. Plasticity of Surface Structures and beta2-adrenergic receptor localization in failing ventricular cardiomyocytes during recovery from heart failure. Circ Heart Fail 2012, 5:357-365.
47. Kranias E.G., Hajjar R.J. Modulation of cardiac contractility by the phospholamban/SERCA2a regulatome. Circ Res 2012, 110:1646-1660.
48. Ibrahim M., Rao C., Athanasiou T., et al. Mechanical unloading and cell therapy have a synergistic role in the recovery and regeneration of the failing heart. Eur J Cardiothorac Surg 2012, 42:312-318.
49. Bergmann O., Bhardwaj R.D., Bernard S., et al. Evidence for cardiomyocyte renewal in humans. Science 2009, 324(5923):98-102.
50. Porrello E.R., Mahmoud A.I., Simpson E., et al. Transient regenerative potential of the neonatal mouse heart. Science 2011, 331(6020):1078-1080.
51. Kubo H., Jaleel N., Kumarapeli A., et al. Increased cardiac myocyte progenitors in failing human hearts. Circulation 2008, 118:649-657.
52. Wohlschlaeger J., Levkau B., Brockhoff G., et al. Hemodynamic support by left ventricular assist devices reduces cardiomyocyte DNA content in the failing human heart. Circulation 2010, 121:989-996.
53. Hassan M., Latif N., Yacoub M. Adipose tissue: friend or foe?. Nat Rev Cardiol 2012, 9:689-702.
54. Farrar D.J., Holman W.R., McBride L.R., et al. Long-term follow-up of Thoratec ventricular assist device bridge-to-recovery patients successfully removed from support after recovery of ventricular function. JHeart Lung Transplant 2002, 21:516-521.
55. Gorcsan J., Severyn D., Murali S., et al. Non-invasive assessment of myocardial recovery on chronic left ventricular assist device: results associated with successful device removal. JHeart Lung Transplant 2003, 22:1304-1313.
56. Simon M.A., Kormos R.L., Murali S., et al. Myocardial recovery using ventricular assist devices: prevalence, clinical characteristics, and outcomes. Circulation 2005, 112(Suppl 9):I32-I36.
57. Matsumiya G., Monta O., Fukushima N., et al. Who would be a candidate for bridge to recovery during prolonged mechanical left ventricular support in idiopathic dilated cardiomyopathy?. JThorac Cardiovasc Surg 2005, 130:699-704.
58. Dandel M., Weng Y., Siniawski H., et al. Long-termresults in patients with idiopathic dilated cardiomyopathy after weaning from left ventricular assist devices. Circulation 2005, 112(Suppl 9):I37-I45.
59. Lamarche Y., Kearns M., Josan K., et al. Successful weaning and explantation of the Heartmate II left ventricular assist device. Can J Cardiol 2011, 27:358-362.
60. Klotz S., Foronjy R.F., Dickstein M.L., et al. Mechanical unloading during left ventricular assist device support increases left ventricular collagen cross-linking and myocardial stiffness. Circulation 2005, 112:364-374.
61. Hattori T. Effect of mechanical assist devices for ischemic myocardial damage-cardiomyocyte apoptosis and TNFalpha. Ann Thorac Cardiovasc Surg 2003, 9:233-240.
62. Levin H.R., Oz M.C., Chen J.M., et al. Reversal of chronic ventricular dilation in patients with end-stage cardiomyopathy by prolonged mechanical unloading. Circulation 1995, 91:2717-2720.
63. Birks E.J., Hall J.L., Barton P.J., et al. Gene profiling changes in cytoskeletal proteins during clinical recovery after left ventricular-assist device support. Circulation 2005, 112(Suppl 9):I57-I64.